Preliminary Outcomes for Treatment of High Intermediate- and High-risk Prostate Cancer Patients using Pelvic Intensity Modulated Radiotherapy with Hypofractionated Simultaneous Integrated Boost to Prostate

被引：2
|
作者：
Reddy, K. [1 ]
Nelson, B. C. [1 ]
McCammon, R. [2 ]
Rusthoven, K. E. [1 ]
Newman, F. [1 ]
Kavanagh, B. [1 ]
Raben, D. [1 ]
机构：
[1] Univ Colorado, Aurora, CO USA
[2] SE Radiat Oncol, Charlotte, NC USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2010年 / 78卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2010.07.887
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S376 / S376
页数：1
相关论文
共 50 条
  • [1] TOXICITY ASSESSMENT OF PELVIC INTENSITY-MODULATED RADIOTHERAPY WITH HYPOFRACTIONATED SIMULTANEOUS INTEGRATED BOOST TO PROSTATE FOR INTERMEDIATE- AND HIGH-RISK PROSTATE CANCER
    McCammon, Robert
    Rusthoven, Kyle E.
    Kavanagh, Brian
    Newell, Sherri
    Newman, Francis
    Raben, David
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (02): : 413 - 420
  • [2] Efficacy of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to the prostate for intermediate-and high-risk prostate cancer
    Reddy, Krishna
    Strom, Tobin
    Plimpton, Reed
    Kavanagh, Brian D.
    Petersen, Jane
    Wilson, Shandra
    Maroni, Paul
    Raben, David
    JOURNAL OF RADIATION ONCOLOGY, 2014, 3 (04) : 401 - 407
  • [3] Hypofractionated Intensity-modulated Radiotherapy for Intermediate- and High-risk Prostate Cancer: A Retrospective Study
    Kubo, Nobuteru
    Kawamura, Hidemasa
    Oike, Takahiro
    Sato, Hiro
    Iwanaga, Mototaro
    Mizukami, Tatsuji
    Adachi, Akiko
    Matsui, Hiroshi
    Ito, Kazuto
    Suzuki, Kazuhiro
    Nakano, Takashi
    IN VIVO, 2019, 33 (04): : 1235 - 1241
  • [4] PELVIC IMRT AND HYPOFRACTIONATED SIMULTANEOUS INTEGRATED BOOST TO HIGH-RISK PROSTATE CANCER
    Alessandro, Magli
    De Giorgi, Gioacchino
    Ceschia, Tino
    Crivellaro, Simone
    Marino, Marco
    Parisi, Giuseppe
    Signor, Marco
    Titone, Francesca
    Frea, Bruno
    Fongione, Sandro
    ANTICANCER RESEARCH, 2011, 31 (05) : 1876 - 1877
  • [5] Hypofractionated intensity-modulated simultaneous integrated boost and image-guided radiotherapy in the treatment of high-risk prostate cancer patients: a preliminary report on acute toxicity
    Valeriani, Maurizio
    Carnevale, Alessia
    Osti, Mattia Falchetto
    Minniti, Giuseppe
    De Sanctis, Vitaliana
    Agolli, Linda
    Bracci, Stefano
    Enrici, Riccardo Maurizi
    TUMORI, 2013, 99 (04) : 474 - 479
  • [6] Hypofractionated versus conventional radiotherapy in intermediate- to high-risk prostate cancer
    Guo, W.
    Gao, X. S.
    Gu, X. B.
    Ma, M. W.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S716 - S716
  • [7] Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer
    Mekhail Anwar
    Vivian Weinberg
    Zachary Seymour
    I. Joe Hsu
    Mack Roach
    Alex R. Gottschalk
    Radiation Oncology, 11
  • [8] Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer
    Anwar, Mekhail
    Weinberg, Vivian V.
    Seymour, Zachary
    Hsu, I. Joe
    Roach, Mack, III
    Gottschalk, Alex R.
    RADIATION ONCOLOGY, 2016, 11
  • [9] Overall Treatment Time and Charlson Score Impact on Toxicity of Intensity Modulated Arc Therapy With Simultaneous Integrated Boost to Prostate for Intermediate- or High-Risk Prostate Cancer
    Ferrer, F.
    Mendez, G.
    Chiruzzi, C.
    Letelier, H. A.
    Boladeras, A.
    De Blas, R.
    Pineiro, R.
    Galdeano, M.
    Najjari, D.
    Zardoya, E.
    Chavez, R.
    Ventura, M.
    Martinez, E.
    Gutierrez, C.
    Picon, C.
    Pera, J.
    Guedea, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E211 - E212
  • [10] Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost and whole pelvic radiotherapy for intermediate- and high-risk prostate cancer
    Kim, Hun Jung
    Phak, Jeong Hoon
    Kim, Woo Chul
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (01) : 21 - 27
12345